CUEDC2 and breast carcinoma: A high expression level of CUEDC2 indicates a significant prognostic value for breast cancer patients [4]; thus, therapeutic drug-targeted CUEDC2 should be considered as a promising approach to eradicate Wnt signaling driving cell populations and, in consequence, TNBC.